Pharmalittle

Pharmalot By Elizabeth Cooney

Pharmalittle: Slaoui vows to quit OWS if politics trumps vaccine science; do we have enough freezers?

Pharmalot By Damian Garde

Pharmalittle: Trump promises a Covid-19 vaccine in 2020; WHO’s grand experiment is faltering

Pharmalot By Ed Silverman

Pharmalittle: Lilly starts late-stage trial of Covid-19 antibody; concern grows over political intervention on Covid-19 vaccine

Pharmalot By Ed Silverman

Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges

Pharmalot By Ed Silverman

Pharmalittle: France piles pressure on Sanofi over Covid-19 vaccine; GOP fails to land a punch on Bright

Pharmalot By Ed Silverman

Pharmalittle: Thousands sign up for trials studying hydroxycholoroquine; Gilead drug fails to help Covid-19 patients

Pharmalot By Ed Silverman

Pharmalittle: Novartis to test hydroxycholoroquine in Covid-19; malaria drug failed to protect lupus patients from coronavirus

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Early data suggests Gilead Covid-19 drug works; did FDA drop standards too far in hunt for chloroquine?

Pharmalot By Ed Silverman

Pharmalittle: More than one coronavirus vaccine may be needed; Utah bill would protect docs prescribing meds for Covid-19

Pharmalot By Ed Silverman

Pharmalittle: Docs ask states for lethal injection drugs to combat Covid-19; Raw material costs for hydroxycholorquine slow production

Pharmalot By Ed Silverman

Pharmalittle: India to ramp up ingredients production; CIA warns employees about taking hydroxycholoroquine

Pharmalot By Ed Silverman

Pharmalittle: Gilead Covid-19 drug shows early promise; AstraZeneca halts trial due to ‘overwhelming’ benefit

Pharmalot By Ed Silverman

Pharmalittle: Poison control sees more cases with malaria drug; India to double HCQ output

Pharmalot By Ed Silverman

Pharmalittle: More clinical trials derailed by Covid-19; Pfizer jumpstarts tests on a drug to fight the pandemic

Pharma By Ed Silverman

Pharmalittle: India to allow limited exports of malaria drug; some Trump allies profit if hydroxychloroquine is approved

Pharmalot By Ed Silverman

Pharmalittle: States try to prevent hoarding of drug used for Covid-19; is BARDA ready for the coronavirus?

Pharmalot By Ed Silverman

Pharmalittle: Sanofi poised to supply millions of doses of malaria drug; Roche unit apologizes for ‘Wuhan’ virus label

Pharmalot By Ed Silverman

Pharmalittle: Novartis scraps generic sale to Aurobindo; another small study suggests old malaria drug works

Pharmalot By Ed Silverman

Pharmalittle: U.S. asks India to list restrictions on pharma ingredients; Giuliani wants FDA to fast-track a drug for Covid-19

Pharmalot By Ed Silverman

Pharmalittle: A TB vaccine is tested against the coronavirus; FDA doesn’t punish Novartis over data integrity scandal

Pharmalot By Ed Silverman

Pharmalittle: Drug pricing legislation is on the back burner; FDA issues emergency use for old malaria drugs

Pharmalot By Ed Silverman

Pharmalittle: Conservative group pushes for malaria drug approval for Covid-19; OTC drug industry to get an overhaul

Pharmalot By Ed Silverman

Pharmalittle: Gilead asks FDA to rescind orphan status for Covid-19 drug; Bristol delays MS drug launch due to coronavirus

Pharmalot By Ed Silverman

Most Read

Pharmalittle: Trump adviser slams PhRMA pushback against ‘American-made’; drug makers boost production of malaria pill for Covid-19

Pharmalittle: Canada may change new rules for drug prices; Trump frustrated over drug pricing

Pharmalittle: Tension in the Verily-Dexcom tango; not so fast on the Pfizer-GSK spinoff

Pharmalittle: Gates Foundation and others plan $125 million coronavirus effort; India considers lifting export restrictions

Pharmalittle: Groups backed by pharma oppose equitable Covid-19 pricing; AstraZeneca strikes big Covid-19 vaccine deal

Pharmalittle: A new scandal for Novartis; opioid distributors offer to settle lawsuits

Pharmalittle: Drug makers spent $120 million lobbying Congress in 2019; more investors are bullish on Biogen’s Alzheimer drug

Pharmalittle: Bristol pushes back Celgene deal; FDA approves another ‘female Viagra’

All Coverage

Pharmalittle: Slaoui vows to quit OWS if politics trumps vaccine science; do we have enough freezers?

Pharmalittle: Trump promises a Covid-19 vaccine in 2020; WHO’s grand experiment is faltering

Pharmalittle: Lilly starts late-stage trial of Covid-19 antibody; concern grows over political intervention on Covid-19 vaccine

Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges

Pharmalittle: France piles pressure on Sanofi over Covid-19 vaccine; GOP fails to land a punch on Bright

Pharmalittle: Thousands sign up for trials studying hydroxycholoroquine; Gilead drug fails to help Covid-19 patients

Pharmalittle: Novartis to test hydroxycholoroquine in Covid-19; malaria drug failed to protect lupus patients from coronavirus

Up and down the ladder: The latest comings and goings

Pharmalittle: Early data suggests Gilead Covid-19 drug works; did FDA drop standards too far in hunt for chloroquine?

Pharmalittle: More than one coronavirus vaccine may be needed; Utah bill would protect docs prescribing meds for Covid-19

Pharmalittle: Docs ask states for lethal injection drugs to combat Covid-19; Raw material costs for hydroxycholorquine slow production

Pharmalittle: India to ramp up ingredients production; CIA warns employees about taking hydroxycholoroquine

Pharmalittle: Gilead Covid-19 drug shows early promise; AstraZeneca halts trial due to ‘overwhelming’ benefit

Pharmalittle: Poison control sees more cases with malaria drug; India to double HCQ output

Pharmalittle: More clinical trials derailed by Covid-19; Pfizer jumpstarts tests on a drug to fight the pandemic

Pharmalittle: India to allow limited exports of malaria drug; some Trump allies profit if hydroxychloroquine is approved

Pharmalittle: States try to prevent hoarding of drug used for Covid-19; is BARDA ready for the coronavirus?

Pharmalittle: Sanofi poised to supply millions of doses of malaria drug; Roche unit apologizes for ‘Wuhan’ virus label

Pharmalittle: Novartis scraps generic sale to Aurobindo; another small study suggests old malaria drug works

Pharmalittle: U.S. asks India to list restrictions on pharma ingredients; Giuliani wants FDA to fast-track a drug for Covid-19

Pharmalittle: A TB vaccine is tested against the coronavirus; FDA doesn’t punish Novartis over data integrity scandal

Pharmalittle: Drug pricing legislation is on the back burner; FDA issues emergency use for old malaria drugs

Pharmalittle: Conservative group pushes for malaria drug approval for Covid-19; OTC drug industry to get an overhaul

Pharmalittle: Gilead asks FDA to rescind orphan status for Covid-19 drug; Bristol delays MS drug launch due to coronavirus

Pharmalittle: Scientists say coronavirus is not mutating significantly; WHO is asked to pool Covid-19 patent rights

pharmalittle

Most Read

All Coverage